This page provides access to essential management and financial information for EDX Medical Group plc, in order to meet the disclosure requirements outlined in Rule 26 of the AIM Rules for Companies.
Last update: 13 April 2026.
Description of the business
EDX Medical Group plc is a UK-based listed company focused on the development and provision of diagnostic tests that enable personalised treatment for major diseases including cancer, cardiovascular and infectious diseases.
Our trusted diagnostic solutions combine outstanding biological and digital technologies. Our molecular biology laboratory in Cambridge, UK, leads our laboratory-based work. Health professionals, wherever they work, use our point-of-care devices to deliver critical patient test results.
Further information can be found here: EDX Medical: the Company
Board of Directors – names & biographies
Names and biographies of the Company’s Directors can be found here:
EDX Medical: board of directors
Board of Directors – responsibilities
Responsibilities of board members and details of board committees can be found here:
EDX Medical: Corporate Governance.
Country of incorporation and main country of operation
EDX Medical Group plc is incorporated in England and Wales with company number: 13277385. Its main country of operation is the UK.
UK City Code on Takeovers and Mergers
EDX Medical Group plc is subject to the UK City Code on Takeovers and Mergers.
Advisers
A list of Company advisers can be found here: https://edxmedical.co.uk/company-advisers/
Company announcements
All announcements made by the Company can be found here: https://edxmedical.co.uk/rns/
Publications
The Company’s Admission Document and current constitutional documents and other circulars can be found here: https://edxmedical.instawp.co/documents/
Financial results
Historical financial results can be viewed here: https://edxmedical.co.uk/documents/
Securities information
Securities information can be found here: https://edxmedical.co.uk/shareholder-analysis/
Corporate governance code
The Company has adopted the QCA Corporate Governance Code. A short explanation of how the Company applies each of the principles can be found here: https://edxmedical.instawp.co/corporate-governance/
Shares not in public hands
39.36 % of the Company’s AIM securities are not held in public hands.
Restrictions in transfer of AIM securities
All shares carry equal voting rights and there are no restrictions on the transfer of the Company’s AIM securities.
Other exchanges and trading platforms
The Company has applied to have its ordinary shares admitted to trading on the AIM market of the London Stock Exchange. The Company has not applied or agreed to have any of its securities admitted to trading on any other exchange or trading platform.
